344 related articles for article (PubMed ID: 23711220)
1. Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis.
Goules JD; Goules AV; Tzioufas AG
Clin Exp Immunol; 2013 Oct; 174(1):10-7. PubMed ID: 23711220
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies.
Reed E; Jiang X; Kharlamova N; Ytterberg AJ; Catrina AI; Israelsson L; Mathsson-Alm L; Hansson M; Alfredsson L; Rönnelid J; Lundberg K
Arthritis Res Ther; 2016 May; 18(1):96. PubMed ID: 27145822
[TBL] [Abstract][Full Text] [Related]
3. Anti-citrullinated glucose-6-phosphate isomerase peptide antibodies in patients with rheumatoid arthritis are associated with HLA-DRB1 shared epitope alleles and disease activity.
Umeda N; Matsumoto I; Ito I; Kawasaki A; Tanaka Y; Inoue A; Tsuboi H; Suzuki T; Hayashi T; Ito S; Tsuchiya N; Sumida T
Clin Exp Immunol; 2013 Apr; 172(1):44-53. PubMed ID: 23480184
[TBL] [Abstract][Full Text] [Related]
4. Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis.
Shoda H; Fujio K; Shibuya M; Okamura T; Sumitomo S; Okamoto A; Sawada T; Yamamoto K
Arthritis Res Ther; 2011; 13(6):R191. PubMed ID: 22108001
[TBL] [Abstract][Full Text] [Related]
5. Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.
Ossipova E; Cerqueira CF; Reed E; Kharlamova N; Israelsson L; Holmdahl R; Nandakumar KS; Engström M; Harre U; Schett G; Catrina AI; Malmström V; Sommarin Y; Klareskog L; Jakobsson PJ; Lundberg K
Arthritis Res Ther; 2014 Aug; 16(4):R167. PubMed ID: 25112157
[TBL] [Abstract][Full Text] [Related]
6. Recognition of new citrulline-containing peptide epitopes by autoantibodies produced in vivo and in vitro by B cells of rheumatoid arthritis patients.
Szarka E; Babos F; Magyar A; Huber K; Szittner Z; Papp K; Prechl J; Pozsgay J; Neer Z; Ádori M; Nagy G; Rojkovich B; Gáti T; Kelemen J; Baka Z; Brózik M; Pazár B; Poór G; Hudecz F; Sármay G
Immunology; 2014 Feb; 141(2):181-91. PubMed ID: 24116744
[TBL] [Abstract][Full Text] [Related]
7. Physical Characteristics of a Citrullinated Pro-Filaggrin Epitope Recognized by Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Sera.
Trier NH; Holm BE; Slot O; Locht H; Lindegaard H; Svendsen A; Houen G
PLoS One; 2016; 11(12):e0168542. PubMed ID: 28002483
[TBL] [Abstract][Full Text] [Related]
8. Application of synthetic peptides for detection of anti-citrullinated peptide antibodies.
Trier NH; Holm BE; Slot O; Locht H; Lindegaard H; Svendsen A; Nielsen CT; Jacobsen S; Theander E; Houen G
Peptides; 2016 Feb; 76():87-95. PubMed ID: 26796582
[TBL] [Abstract][Full Text] [Related]
9. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
[TBL] [Abstract][Full Text] [Related]
10. Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins.
Sebbag M; Moinard N; Auger I; Clavel C; Arnaud J; Nogueira L; Roudier J; Serre G
Eur J Immunol; 2006 Aug; 36(8):2250-63. PubMed ID: 16838278
[TBL] [Abstract][Full Text] [Related]
11. Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.
Schwenzer A; Jiang X; Mikuls TR; Payne JB; Sayles HR; Quirke AM; Kessler BM; Fischer R; Venables PJ; Lundberg K; Midwood KS
Ann Rheum Dis; 2016 Oct; 75(10):1876-83. PubMed ID: 26659718
[TBL] [Abstract][Full Text] [Related]
12. Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens.
Fernandes-Cerqueira C; Ossipova E; Gunasekera S; Hansson M; Mathsson L; Catrina AI; Sommarin Y; Klareskog L; Lundberg K; Rönnelid J; Göransson U; Jakobsson PJ
Arthritis Res Ther; 2015 Jun; 17(1):155. PubMed ID: 26059223
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Autoantigens Targeted by Anti-Citrullinated Protein Antibodies In Vivo: Prominent Role for Epitopes Derived from Histone 4 Proteins.
Meng X; Ezzati P; Smolik I; Bernstein CN; Hitchon CA; El-Gabalawy HS
PLoS One; 2016; 11(10):e0165501. PubMed ID: 27788229
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis.
Won P; Kim Y; Jung H; Rim YA; Sohn DH; Robinson WH; Moon SJ; Ju JH
Front Immunol; 2021; 12():692242. PubMed ID: 34305925
[TBL] [Abstract][Full Text] [Related]
15. The fibrin-derived citrullinated peptide β60-74Cit₆₀,₇₂,₇₄ bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies.
Cornillet M; Sebbag M; Verrouil E; Magyar A; Babos F; Ruyssen-Witrand A; Hudecz F; Cantagrel A; Serre G; Nogueira L
Ann Rheum Dis; 2014 Jun; 73(6):1246-52. PubMed ID: 23636655
[TBL] [Abstract][Full Text] [Related]
16. A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.
Grönwall C; Liljefors L; Bang H; Hensvold AH; Hansson M; Mathsson-Alm L; Israelsson L; Joshua V; Svärd A; Stålesen R; Titcombe PJ; Steen J; Piccoli L; Sherina N; Clavel C; Svenungsson E; Gunnarsson I; Saevarsdottir S; Kastbom A; Serre G; Alfredsson L; Malmström V; Rönnelid J; Catrina AI; Lundberg K; Klareskog L
Front Immunol; 2021; 12():627986. PubMed ID: 34093522
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody against citrullinated peptides obtained from rheumatoid arthritis patients reacts with numerous citrullinated microbial and food proteins.
Tsuda R; Ozawa T; Kobayashi E; Hamana H; Taki H; Tobe K; Sugiyama E; Iwamoto M; Imura J; Kishi H; Muraguchi A
Arthritis Rheumatol; 2015 May; 67(8):2020-31. PubMed ID: 25892475
[TBL] [Abstract][Full Text] [Related]
18. Post-translational modifications of the major linear epitope 169-190aa of Ro60 kDa autoantigen alter the autoantibody binding.
Terzoglou AG; Routsias JG; Moutsopoulos HM; Tzioufas AG
Clin Exp Immunol; 2006 Oct; 146(1):60-5. PubMed ID: 16968399
[TBL] [Abstract][Full Text] [Related]
19. Cross-reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 2B protein.
Stathopoulou EA; Routsias JG; Stea EA; Moutsopoulos HM; Tzioufas AG
Clin Exp Immunol; 2005 Jul; 141(1):148-54. PubMed ID: 15958081
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome.
Nezos A; Cinoku I; Mavragani CP; Moutsopoulos HM
Clin Immunol; 2017 Oct; 183():300-303. PubMed ID: 28919520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
